Kronos Bio Inc. (NASDAQ: KRON)
$1.35
-0.1500 ( -10.00% ) 195.0K
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.
Market Data
Open
$1.35
Previous close
$1.50
Volume
195.0K
Market cap
$85.94M
Day range
$1.35 - $1.51
52 week range
$0.69 - $2.28
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 12, 2024 |
3 | Insider transactions | 2 | Jun 04, 2024 |
4 | Insider transactions | 1 | Jun 04, 2024 |
8-k | 8K-related | 14 | May 21, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 70 | May 09, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
def | Proxies and info statements | 28 | Apr 29, 2024 |
10-k | Annual reports | 94 | Mar 21, 2024 |
8-k | 8K-related | 15 | Mar 21, 2024 |